TrialBlood2019

Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study.

Austin G Kulasekararaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.